These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

288 related articles for article (PubMed ID: 36188218)

  • 1. Systemic tryptophan homeostasis.
    Klaessens S; Stroobant V; De Plaen E; Van den Eynde BJ
    Front Mol Biosci; 2022; 9():897929. PubMed ID: 36188218
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tryptophanemia is controlled by a tryptophan-sensing mechanism ubiquitinating tryptophan 2,3-dioxygenase.
    Klaessens S; Stroobant V; Hoffmann D; Gyrd-Hansen M; Pilotte L; Vigneron N; De Plaen E; Van den Eynde BJ
    Proc Natl Acad Sci U S A; 2021 Jun; 118(23):. PubMed ID: 34074763
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tryptophan depletion sensitizes the AHR pathway by increasing AHR expression and GCN2/LAT1-mediated kynurenine uptake, and potentiates induction of regulatory T lymphocytes.
    Solvay M; Holfelder P; Klaessens S; Pilotte L; Stroobant V; Lamy J; Naulaerts S; Spillier Q; Frédérick R; De Plaen E; Sers C; Opitz CA; Van den Eynde BJ; Zhu J
    J Immunother Cancer; 2023 Jun; 11(6):. PubMed ID: 37344101
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tryptophan: A Rheostat of Cancer Immune Escape Mediated by Immunosuppressive Enzymes IDO1 and TDO.
    Kim M; Tomek P
    Front Immunol; 2021; 12():636081. PubMed ID: 33708223
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tryptophan 2,3-Dioxygenase Expression Identified in Murine Decidual Stromal Cells Is Not Essential for Feto-Maternal Tolerance.
    Hoffmann D; Dvorakova T; Schramme F; Stroobant V; Van den Eynde BJ
    Front Immunol; 2020; 11():601759. PubMed ID: 33363543
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification and Characterization of a Novel Dual Inhibitor of Indoleamine 2,3-dioxygenase 1 and Tryptophan 2,3-dioxygenase.
    Yoshioka S; Ikeda T; Fukuchi S; Kawai Y; Ohta K; Murakami H; Ogo N; Muraoka D; Takikawa O; Asai A
    Int J Tryptophan Res; 2022; 15():11786469221138456. PubMed ID: 36467776
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting Indoleamine Dioxygenase and Tryptophan Dioxygenase in Cancer Immunotherapy: Clinical Progress and Challenges.
    Peng X; Zhao Z; Liu L; Bai L; Tong R; Yang H; Zhong L
    Drug Des Devel Ther; 2022; 16():2639-2657. PubMed ID: 35965963
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Indoleamine dioxygenase and tryptophan dioxygenase activities are regulated through GAPDH- and Hsp90-dependent control of their heme levels.
    Biswas P; Dai Y; Stuehr DJ
    Free Radic Biol Med; 2022 Feb; 180():179-190. PubMed ID: 35051612
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tryptophan and indole metabolism in immune regulation.
    Fiore A; Murray PJ
    Curr Opin Immunol; 2021 Jun; 70():7-14. PubMed ID: 33418116
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reversal of tumoral immune resistance by inhibition of tryptophan 2,3-dioxygenase.
    Pilotte L; Larrieu P; Stroobant V; Colau D; Dolusic E; Frédérick R; De Plaen E; Uyttenhove C; Wouters J; Masereel B; Van den Eynde BJ
    Proc Natl Acad Sci U S A; 2012 Feb; 109(7):2497-502. PubMed ID: 22308364
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Indoleamine 2,3-dioxygenase 1 deficiency attenuates CCl4-induced fibrosis through Th17 cells down-regulation and tryptophan 2,3-dioxygenase compensation.
    Zhong W; Gao L; Zhou Z; Lin H; Chen C; Huang P; Huang W; Zhou C; Huang S; Nie L; Liu Y; Chen Y; Zhou D; Lv Z
    Oncotarget; 2017 Jun; 8(25):40486-40500. PubMed ID: 28465467
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tryptophan degradation enzymes and Angiotensin (1-7) expression in human placenta.
    Silvano A; Seravalli V; Strambi N; Tartarotti E; Tofani L; Calosi L; Parenti A; Di Tommaso M
    J Reprod Immunol; 2022 Sep; 153():103692. PubMed ID: 35970080
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discovery and biological evaluation of tanshinone derivatives as potent dual inhibitors of indoleamine 2, 3-dioxygenase 1 and tryptophan 2, 3-dioxygenase.
    Liu J; Ren J; Yang K; Chen S; Yang X; Zhao QS
    Eur J Med Chem; 2022 May; 235():114294. PubMed ID: 35358772
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation and comparison of the commonly used bioassays of human indoleamine 2,3-dioxygenase 1 (IDO1) and tryptophan 2,3-dioxygenase (TDO).
    Zhang S; Guo L; Yang D; Xing Z; Li W; Kuang C; Yang Q
    Bioorg Chem; 2020 Nov; 104():104348. PubMed ID: 33142415
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tryptophan 2,3-dioxygenase in tumor cells is associated with resistance to immunotherapy in renal cell carcinoma.
    Sumitomo M; Takahara K; Zennami K; Nagakawa T; Maeda Y; Shiogama K; Yamamoto Y; Muto Y; Nukaya T; Takenaka M; Fukaya K; Ichino M; Sasaki H; Saito K; Shiroki R
    Cancer Sci; 2021 Mar; 112(3):1038-1047. PubMed ID: 33410234
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunological Relevance of the Coevolution of IDO1 and AHR.
    Jaronen M; Quintana FJ
    Front Immunol; 2014; 5():521. PubMed ID: 25368620
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Heme-containing enzymes and inhibitors for tryptophan metabolism.
    Yan D; Lin YW; Tan X
    Metallomics; 2017 Sep; 9(9):1230-1240. PubMed ID: 28650043
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular evolution of bacterial indoleamine 2,3-dioxygenase.
    Yuasa HJ; Ushigoe A; Ball HJ
    Gene; 2011 Oct; 485(1):22-31. PubMed ID: 21689736
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IDO1/TDO dual inhibitor RY103 targets Kyn-AhR pathway and exhibits preclinical efficacy on pancreatic cancer.
    Liang H; Li T; Fang X; Xing Z; Zhang S; Shi L; Li W; Guo L; Kuang C; Liu H; Yang Q
    Cancer Lett; 2021 Dec; 522():32-43. PubMed ID: 34520819
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of Tryptophan-Dioxygenase Activity Increases the Antitumor Efficacy of Immune Checkpoint Inhibitors.
    Schramme F; Crosignani S; Frederix K; Hoffmann D; Pilotte L; Stroobant V; Preillon J; Driessens G; Van den Eynde BJ
    Cancer Immunol Res; 2020 Jan; 8(1):32-45. PubMed ID: 31806638
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.